Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GHU Paris psychiatrie & neurosciences is a large public university hospital group in Paris focused on psychiatry, mental health, addiction medicine, and neurosciences. Created on January 1, 2019 from the merger of Sainte-Anne, Maison Blanche, and Perray-Vaucluse, it operates a broad network of hospital and community care sites across Paris and surrounding areas. The organization provides inpatient and outpatient psychiatric care, neurology and neurosurgery-related services, addiction treatment, teaching, and clinical research. It is not a biotech or pharmaceutical developer, but rather a healthcare delivery and academic research institution with capabilities in clinical trials and innovation in neuropsychiatric care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GHU Paris psychiatrie & neurosciences.